Remove companies amgen-inc
article thumbnail

Shaping the Future of Patent Law: The Amgen v. Sanofi Decision and Bite-Sized Monopolies

Patently O

.” In a unanimous opinion delivered by Justice Gorsuch, the Supreme Court has affirmed the Federal Circuit’s decision invalidating Amgen’s functionally claimed genus of monoclonal antibodies. The case in question is Amgen Inc. Sanofi , 22-157, — U.S. — (2023) ( 21-757_k5g1 ).

Laws 122
article thumbnail

Supreme Court rules invalid Amgen’s patent on cholesterol-lowering drug

SCOTUSBlog

Share The Supreme Court on Thursday ruled against the drug company Amgen, which had sued Sanofi for infringing Amgen’s patent on antibodies that lower LDL cholesterol, sometimes called “bad” cholesterol. Justice Neil Gorsuch wrote for a unanimous court in Amgen Inc. Amgen failed this test.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Court to decide how specific a patent disclosure must be

SCOTUSBlog

In Amgen Inc. Sanofi , the justices will consider whether Amgen’s patent is too broad to be valid under federal patent rules. Amgen has patents on monoclonal antibodies that lower LDL, or “bad,” cholesterol. Sanofi claims that what Amgen did in this case was “claim a lot and disclose a little.”

Court 112
article thumbnail

Regeneron-Amgen Drug Bundling Trial Heads Toward Jury

Law 360

An economics expert called by Amgen Inc. told a Delaware federal jury Tuesday that none of the company's deals to bundle other discounted major medications with its cholesterol-reducing drug Repatha foreclosed market competition, a day before jurors begin deliberating on an antitrust suit targeting the practice.

52
article thumbnail

Regeneron, Amgen Open Drug 'Bundling' Trial In Del.

Law 360

The founder and CEO of Regeneron Inc. told a federal jury in Delaware on Monday that a major pharmacy benefit insurer told him in mid-2020 his company was wasting its time in trying to keep a cholesterol-drug supply contract, with Amgen Inc. offering a better-priced but allegedly anticompetitive multidrug portfolio.

article thumbnail

Remote Legal Jobs

InHouseBlog

These jobs range from pure TELECOMMUTE jobs, to jobs presently remote that may go on-site at a later time, to flexible hybrids that vary from company to company. More and more companies are recognizing that they can operate effectively in a work from home world, and this can bring tremendous benefits to both employers and employees.

Legal 81
article thumbnail

Amgen Faces Derivative Suit In Del. Over Tax Disclosures

Law 360

An Amgen Inc. stockholder has sued the company in Delaware's Court of Chancery seeking derivative recoveries for the multinational biopharmaceutical company from its directors and officers based on allegedly false and misleading statements regarding $10.7 billion in federal tax bills and penalties.

Court 52